NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Index- P/E73.16 EPS (ttm)0.22 Insider Own2.30% Shs Outstand174.42M Perf Week3.06%
Market Cap2.76B Forward P/E32.02 EPS next Y0.49 Insider Trans0.00% Shs Float170.42M Perf Month7.55%
Enterprise Value2.02B PEG1.30 EPS next Q1.42 Inst Own3.82% Short Float0.26% Perf Quarter-0.57%
Income37.70M P/S4.38 EPS this Y887.87% Inst Trans-4.92% Short Ratio4.80 Perf Half Y10.10%
Sales629.37M P/B3.63 EPS next Y-75.01% ROA2.95% Short Interest0.44M Perf YTD9.72%
Book/sh4.36 P/C3.30 EPS next 5Y56.42% ROE5.06% 52W High21.50 -26.47% Perf Year-9.97%
Cash/sh4.79 P/FCF- EPS past 3/5Y- - ROIC4.58% 52W Low11.51 37.42% Perf 3Y18.87%
Dividend Est.- EV/EBITDA- Sales past 3/5Y20.96% 25.20% Gross Margin44.63% Volatility1.97% 2.36% Perf 5Y-39.17%
Dividend TTM- EV/Sales3.21 EPS Y/Y TTM-63.36% Oper. Margin-6.94% ATR (14)0.54 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.70 Sales Y/Y TTM-25.48% Profit Margin5.99% RSI (14)55.21 Recom1.45
Dividend Gr. 3/5Y- - Current Ratio2.83 EPS Q/Q-79.15% SMA20-0.21% Beta0.53 Target Price25.35
Payout0.00% Debt/Eq0.12 Sales Q/Q53.61% SMA506.52% Rel Volume0.65 Prev Close15.69
Employees1811 LT Debt/Eq0.08 EarningsMar 19 AMC SMA200-0.41% Avg Volume91.92K Price15.81
IPOMar 17, 2016 Option/ShortYes / Yes EPS/Sales Surpr.75.00% 2.30% Trades Volume59,320 Change0.76%
Date Action Analyst Rating Change Price Target Change
May-13-25Downgrade HSBC Securities Buy → Hold
Nov-24-23Upgrade Deutsche Bank Hold → Buy
May-04-22Downgrade Deutsche Bank Buy → Hold
Sep-22-21Downgrade Goldman Buy → Neutral $46
Aug-03-21Initiated Jefferies Buy $52
Oct-02-20Initiated Deutsche Bank Buy $40
Mar-13-20Initiated Cantor Fitzgerald Overweight
Feb-20-20Initiated Goldman Buy
Nov-19-19Initiated CLSA Buy
Oct-23-19Reiterated BofA/Merrill Buy $35 → $29
Jul-03-25 04:30AM
Jun-30-25 04:30AM
Jun-23-25 09:55AM
Jun-05-25 09:55AM
Jun-04-25 07:45PM
08:00PM Loading…
Jun-01-25 08:00PM
May-22-25 08:00PM
May-16-25 08:35AM
May-13-25 03:00AM
May-12-25 08:00PM
May-08-25 10:44AM
08:35AM
Apr-23-25 08:00PM
Apr-21-25 08:00PM
Mar-21-25 06:00AM
05:30AM Loading…
Mar-20-25 05:30AM
03:01AM
Mar-19-25 08:00PM
12:17PM
07:00AM
Mar-18-25 08:00PM
Mar-06-25 05:00AM
Mar-05-25 05:00AM
Feb-19-25 03:30AM
Feb-12-25 10:25AM
Jan-13-25 11:00PM
Jan-02-25 09:15AM
Jan-01-25 07:00PM
05:46AM
Dec-12-24 07:00PM
11:00PM Loading…
Dec-11-24 11:00PM
Dec-03-24 07:00PM
05:00AM
Nov-28-24 05:30AM
Nov-21-24 11:30PM
Nov-20-24 04:30AM
Nov-05-24 11:00PM
Oct-31-24 04:30AM
Oct-16-24 12:30AM
Oct-09-24 03:30PM
Oct-04-24 09:00AM
Sep-26-24 08:51AM
Sep-24-24 03:00AM
Sep-19-24 02:30AM
Sep-17-24 11:22AM
Sep-08-24 08:00PM
Aug-30-24 12:30AM
Aug-28-24 12:24PM
Aug-21-24 04:30AM
Jul-31-24 07:00AM
Jul-03-24 08:00PM
Jun-26-24 04:30AM
Jun-24-24 05:30AM
Jun-21-24 04:00PM
Jun-16-24 08:00PM
Jun-06-24 08:00PM
Jun-02-24 08:00PM
May-23-24 08:00PM
May-17-24 10:00AM
May-16-24 08:00PM
May-13-24 08:00PM
08:00PM
08:00PM
May-08-24 04:30AM
Apr-30-24 12:00PM
09:55AM
Apr-26-24 08:30AM
Apr-05-24 04:30AM
Apr-02-24 12:30AM
Mar-27-24 08:00PM
08:00PM
Mar-21-24 08:00PM
Feb-28-24 06:30AM
Feb-06-24 07:00PM
Feb-02-24 03:30AM
Feb-01-24 03:30AM
Jan-29-24 11:53PM
Jan-10-24 07:00PM
Dec-12-23 11:30PM
07:00PM
Nov-30-23 07:00PM
Nov-10-23 08:35AM
Nov-08-23 07:11PM
Nov-01-23 08:35AM
Oct-31-23 08:35PM
Oct-16-23 04:30AM
Oct-10-23 12:08PM
Oct-05-23 05:17PM
Sep-29-23 04:30AM
Sep-25-23 12:20PM
Sep-18-23 12:14PM
Sep-12-23 04:30AM
Sep-11-23 08:00PM
12:14PM
Aug-28-23 08:00PM
Aug-20-23 08:00PM
Aug-03-23 01:07AM
Jul-31-23 07:41AM
Jul-19-23 08:00PM
Jul-13-23 04:30AM
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.